REPORT HIGHLIGHT
Live Cell Encapsulation Market size was valued at USD 230.8 Million in 2022, expanding at a CAGR of 3.9% from 2023 to 2030.
Using live cell encapsulation, many diseases can be treated. The live cells are enclosed in safe, biocompatible capsules using live cell encapsulation technology. The capsules are open to the blood and nutrients, which feed and sustain the living cells inside. The capsules shield the living cells from the body's immune system destroying them. Within the patient's body, the encapsulated cells are slowly discharged. Furthermore, these cells may be employed to undertake in-vivo research without harming the host DNA.
Live Cell Encapsulation Market- Market Dynamics:
- Technological advancements and novel product launch drives the market growth.
- Key companies' new product launches and technological developments are expected to provide attractive market prospects. For instance, Hydrobio INX N400, the first commercially available bioresin that combines live cell encapsulation with high-resolution biofabrication, was presented by BIO INX in November 2022. Similar to this, ViaCyte, Inc. created two ground-breaking regenerative medicine technology platforms. Various human ailments and diseases that may be treated by replacing damaged or missing cells are addressed by the Encaptra system for cell encapsulation & implantation and stem cell-derived cell replacement treatments. Thus, this is expected to drive market growth during the forecast period.
Live Cell Encapsulation Market- Key Insights:
- As per the analysis shared by our research analyst, the global Live Cell Encapsulation market is estimated to grow annually at a CAGR of around 3.9% over the forecast period (2023-2030)
- The Live Cell Encapsulation industry is projected to grow at a significant rate owing to the growing demand for food testing to ensure the quality
- Based on industry scope, the clinical diagnostics segment is expected to dominate the market during the forecast period
- Based on the technology, the cell culture segment is expected to hold a significant market share over the forecast period
- Based on region, North America is expected to dominate the market during the forecast period
Live Cell Encapsulation Market- Segmentation Analysis:
- The Global Live Cell Encapsulation Market is segmented based on polymer type, method, application, and Region.
- Based on polymer type, the global Live Cell Encapsulation market is segmented into natural and synthetic. The natural segment is expected to dominate the market during the forecast period. The most popular alternative for encapsulation is natural polymers. Large-molecular-weight macromolecules known as "natural polymers" are those that are sourced from nature and are preferred because they are biodegradable, non-toxic, biocompatible, renewable, and adaptable to changes. Since they have a natural origin, such as bacteria, animals, and plants, they can interact with cells and tissues by displaying characteristics that the body recognizes and as a consequence does not perceive them as foreign objects. To transport and distribute hydrophobic or hydrophilic active components, which may be in solid, liquid, or gaseous phases, to the needed places, natural polymers, such as lipids, proteins, and polysaccharides have been used as encapsulation. Thereby, driving the market growth over the forecast period.
Live Cell Encapsulation Market- Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The market's expansion can be attributed to several factors, including the existence of major players, rising healthcare spending per person, increased funding and investment in research and development programs in the US and Canada, and well-established healthcare infrastructure. According to a report from the Pharmaceutical Research and Manufacturers of America (PhRMA) released in September 2021, biopharmaceutical companies invested more than $1 trillion in research and development up until that point. PhRMA member companies invested about USD 91 billion in that same period. In addition, the Government of Alberta announced in December 2021 financing of USD 5.6 million to support Alberta's life sciences and pharmaceutical industry in Canada. Thereby, driving the market growth in the region.
Live Cell Encapsulation Market- Competitive Landscape:
The Live Cell Encapsulation Market's top players use technology launches, acquisitions, and R&D efforts as their primary business strategies. The key players operating in the market are BIO INX, Isogen, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), AUSTRIANOVA, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc., Merck KGaA and Diatranz Otsuka Ltd.
Recent Developments:
In March 2022, for its clinical trial product candidate, CypCaps, PharmaCyte Biotech, Inc. announced completing a 24-month product stability study mandated by the United States Food and Drug Administration (FDA). At this point, CypCaps has proven to have a shelf life of at least 24 months when kept at -80 degrees Celsius, making it significant.
Key features of the study:
- This proposed research study on Live Cell Encapsulation market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Live Cell Encapsulation market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Live Cell Encapsulation market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Live Cell Encapsulation market
- Impact of COVID-19 on Live Cell Encapsulation market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Live Cell Encapsulation market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Live Cell Encapsulation market, we have also included competitive landscape and key innovator analysis for the Live Cell Encapsulation market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Live Cell Encapsulation market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Live Cell Encapsulation market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LIVE CELL ENCAPSULATION MARKET KEY PLAYERS
- BIO INX
- Isogen
- Sphere Fluidics Ltd.
- ViaCyte, Inc.
- Blacktrace Holdings Ltd. (Dolomite Microfluidics)
- AUSTRIANOVA
- Living Cell Technologies Ltd.
- Sigilon Therapeutics, Inc.
- Merck KGaA
- Diatranz Otsuka Ltd.
GLOBAL LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE
- Natural Polymers
- Synthetic Polymers
GLOBAL LIVE CELL ENCAPSULATION MARKET, BY METHOD
- Microencapsulation
- Macroencapsulation
- Nanoencapsulation
GLOBAL LIVE CELL ENCAPSULATION MARKET, BY APPLICATION
- Drug Delivery
- Regenerative Medicine
- Cell Transplantation
- Others
GLOBAL LIVE CELL ENCAPSULATION MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA